Gan & Lee Pharmaceuticals. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 560.33 million compared to CNY 558 million a year ago.

Revenue was CNY 560.33 million compared to CNY 558 million a year ago. Net income was CNY 96 million compared to CNY 49.22 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.09 a year ago.

Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.09 a year ago.